ArticleMolecular medicine (Cambridge, Mass.)2023

Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options.

Margaretha A Skowron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.